Maternal and Child Health, Non-Communicable Diseases and Metabolites
Mothers influence the health and disease trajectories of their children, particularly during the critical developmental windows of fetal and neonatal life reflecting the gestational–fetal and lactational–neonatal phases. As children grow and develop, they are exposed to various stimuli and insults,...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-06-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/13/6/756 |
| _version_ | 1797593496847122432 |
|---|---|
| author | Marlon E. Cerf |
| author_facet | Marlon E. Cerf |
| author_sort | Marlon E. Cerf |
| collection | DOAJ |
| description | Mothers influence the health and disease trajectories of their children, particularly during the critical developmental windows of fetal and neonatal life reflecting the gestational–fetal and lactational–neonatal phases. As children grow and develop, they are exposed to various stimuli and insults, such as metabolites, that shape their physiology and metabolism to impact their health. Non-communicable diseases, such as diabetes, cardiovascular disease, cancer and mental illness, have high global prevalence and are increasing in incidence. Non-communicable diseases often overlap with maternal and child health. The maternal milieu shapes progeny outcomes, and some diseases, such as gestational diabetes and preeclampsia, have gestational origins. Metabolite aberrations occur from diets and physiological changes. Differential metabolite profiles can predict the onset of non-communicable diseases and therefore inform prevention and/or better treatment. In mothers and children, understanding the metabolite influence on health and disease can provide insights for maintaining maternal physiology and sustaining optimal progeny health over the life course. The role and interplay of metabolites on physiological systems and signaling pathways in shaping health and disease present opportunities for biomarker discovery and identifying novel therapeutic agents, particularly in the context of maternal and child health, and non-communicable diseases. |
| first_indexed | 2024-03-11T02:10:01Z |
| format | Article |
| id | doaj.art-1bec730db5fc41abaf6351ab5b5cae7e |
| institution | Directory Open Access Journal |
| issn | 2218-1989 |
| language | English |
| last_indexed | 2024-03-11T02:10:01Z |
| publishDate | 2023-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Metabolites |
| spelling | doaj.art-1bec730db5fc41abaf6351ab5b5cae7e2023-11-18T11:35:15ZengMDPI AGMetabolites2218-19892023-06-0113675610.3390/metabo13060756Maternal and Child Health, Non-Communicable Diseases and MetabolitesMarlon E. Cerf0Grants, Innovation and Product Development, South African Medical Research Council, P.O. Box 19070, Tygerberg, Cape Town 7505, South AfricaMothers influence the health and disease trajectories of their children, particularly during the critical developmental windows of fetal and neonatal life reflecting the gestational–fetal and lactational–neonatal phases. As children grow and develop, they are exposed to various stimuli and insults, such as metabolites, that shape their physiology and metabolism to impact their health. Non-communicable diseases, such as diabetes, cardiovascular disease, cancer and mental illness, have high global prevalence and are increasing in incidence. Non-communicable diseases often overlap with maternal and child health. The maternal milieu shapes progeny outcomes, and some diseases, such as gestational diabetes and preeclampsia, have gestational origins. Metabolite aberrations occur from diets and physiological changes. Differential metabolite profiles can predict the onset of non-communicable diseases and therefore inform prevention and/or better treatment. In mothers and children, understanding the metabolite influence on health and disease can provide insights for maintaining maternal physiology and sustaining optimal progeny health over the life course. The role and interplay of metabolites on physiological systems and signaling pathways in shaping health and disease present opportunities for biomarker discovery and identifying novel therapeutic agents, particularly in the context of maternal and child health, and non-communicable diseases.https://www.mdpi.com/2218-1989/13/6/756cancercardiovascular diseasedevelopmental programmingdiabetesgut microbiotamental illness |
| spellingShingle | Marlon E. Cerf Maternal and Child Health, Non-Communicable Diseases and Metabolites Metabolites cancer cardiovascular disease developmental programming diabetes gut microbiota mental illness |
| title | Maternal and Child Health, Non-Communicable Diseases and Metabolites |
| title_full | Maternal and Child Health, Non-Communicable Diseases and Metabolites |
| title_fullStr | Maternal and Child Health, Non-Communicable Diseases and Metabolites |
| title_full_unstemmed | Maternal and Child Health, Non-Communicable Diseases and Metabolites |
| title_short | Maternal and Child Health, Non-Communicable Diseases and Metabolites |
| title_sort | maternal and child health non communicable diseases and metabolites |
| topic | cancer cardiovascular disease developmental programming diabetes gut microbiota mental illness |
| url | https://www.mdpi.com/2218-1989/13/6/756 |
| work_keys_str_mv | AT marlonecerf maternalandchildhealthnoncommunicablediseasesandmetabolites |